Deutsche Bank Maintains Hold on Bristol-Myers Squibb, Lowers Price Target to $45
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst James Shin maintains a Hold rating on Bristol-Myers Squibb (NYSE:BMY) but lowers the price target from $53 to $45.
July 23, 2024 | 11:26 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Deutsche Bank analyst James Shin maintains a Hold rating on Bristol-Myers Squibb (NYSE:BMY) but lowers the price target from $53 to $45.
The lowered price target from $53 to $45 by Deutsche Bank suggests a less optimistic outlook for Bristol-Myers Squibb, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100